Landos Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q1 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Landos Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q1 2022.
Landos Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2022 was $700K.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2022	$700K			Mar 31, 2022	10-K	2024-03-21
Q4 2021	$800K			Jan 1, 2022	10-K	2023-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.